Cargando…
In situ characterization of stem cells-like biomarkers in meningiomas
BACKGROUND: Meningioma cancer stem cells (MCSCs) contribute to tumor aggressiveness and drug resistance. Successful therapies developed for inoperable, recurrent, or metastatic tumors must target these cells and restrict their contribution to tumor progression. Unfortunately, the identity of MCSCs r...
Autores principales: | Alamir, Hanin, Alomari, Mona, Salwati, Abdulla Ahmed A., Saka, Mohamad, Bangash, Mohammed, Baeesa, Saleh, Alghamdi, Fahad, Carracedo, Angel, Schulten, Hans-Juergen, Chaudhary, Adeel, Abuzenadah, Adel, Hussein, Deema |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5970464/ https://www.ncbi.nlm.nih.gov/pubmed/29849507 http://dx.doi.org/10.1186/s12935-018-0571-6 |
Ejemplares similares
-
Overlapping variants in the blood, tissues and cell lines for patients with intracranial meningiomas are predominant in stem cell-related genes
por: Hussein, Deema, et al.
Publicado: (2020) -
A paediatric dysembryoplastic neuroepithelial tumour (DNET) with deregulated stem cell markers: a case report
por: Hussein, Deema, et al.
Publicado: (2022) -
The anterior gradient homologue 2 (AGR2) co-localises with the glucose-regulated protein 78 (GRP78) in cancer stem cells, and is critical for the survival and drug resistance of recurrent glioblastoma: in situ and in vitro analyses
por: Hussein, Deema, et al.
Publicado: (2022) -
Pleomorphism and drug resistant cancer stem cells are characteristic of aggressive primary meningioma cell lines
por: Khan, Ishaq, et al.
Publicado: (2017) -
Microarray Expression Data Identify DCC as a Candidate Gene for Early Meningioma Progression
por: Schulten, Hans-Juergen, et al.
Publicado: (2016)